title: Can vaginal misoprostol be administered 1 to 3 days after mifepristone without loss of efficacy or an increase in adverse events?
authors.affiliation: University of Michigan, Ann Arbor, USA. Caroli@umich.edu
authors.forename: C R
authors.initials: CR
authors.lastname: Richardson
mesh_terms: D000020:Abortifacient Agents, Nonsteroidal / Q000008:administration & dosage*; D000021:Abortifacient Agents, Steroidal / Q000008:administration & dosage*; D000028:Abortion, Induced; D000282:Administration, Intravaginal; D005260:Female; D006801:Humans; D015735:Mifepristone / Q000008:administration & dosage*; D016595:Misoprostol / Q000008:administration & dosage*; D015337:Multicenter Studies as Topic; D017060:Patient Satisfaction; D011247:Pregnancy; D016032:Randomized Controlled Trials as Topic
chemical_list: D000020:Abortifacient Agents, Nonsteroidal; D000021:Abortifacient Agents, Steroidal; D016595:Misoprostol; D015735:Mifepristone